Boston Scientific Corporation

Recent News About Boston Scientific Corporation View More

BOSTON SCIENTIFIC CORPORATION: Boston Scientific Announces Conference Call Discussing Second Quarter 2019 Financial Results

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2019 on Wednesday, July 24, 2019 at 8:00 a.m.

BOSTON SCIENTIFIC CORPORATION: Boston Scientific Prices $4.3 Billion of Senior Notes

Boston Scientific Corporation (NYSE: BSX) announced the pricing of a public offering of $4.3 billion aggregate principal amount of its senior notes under the Company's shelf registration statement.

BOSTON SCIENTIFIC CORPORATION: Boston Scientific Participates in FDA General Issues Panel on Transvaginal Surgical Mesh for Pelvic Organ Prolapse

On February 12, 2019, the U.S. Food and Drug Administration (FDA) convened an advisory panel of experts to discuss the safety and effectiveness of surgical mesh placed transvaginally to treat pelvic organ prolapse (POP).

Boston Scientific Corporation Upcoming Events View More

No Events

Metro Business Network